American Journal of Ophthalmology
Volume 143, Issue 6 , Pages 984-994.e1 , June 2007

Central Retinal Sensitivity Measured with the Micro Perimeter 1 After Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

  • Yuko Yodoi

      Affiliations

    • Department of Ophthalmology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Akitaka Tsujikawa

      Affiliations

    • Department of Ophthalmology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • Corresponding Author InformationInquiries to Akitaka Tsujikawa, Department of Ophthalmology, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Takanori Kameda

      Affiliations

    • Department of Ophthalmology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Atsushi Otani

      Affiliations

    • Department of Ophthalmology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Hiroshi Tamura

      Affiliations

    • Department of Ophthalmology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Michiko Mandai

      Affiliations

    • Department of Experimental Therapeutics, Translational Research Center, Kyoto University Hospital, Kyoto, Japan.
    • ,
  • Nagahisa Yoshimura

      Affiliations

    • Department of Ophthalmology, Kyoto University Graduate School of Medicine, Kyoto, Japan

,Accepted 14 January 2007.

References 

  1. Kleiner RC, Brucker AJ, Johnston RL. The posterior uveal bleeding syndrome. Retina. 1990;10:9–17
  2. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina. 1990;10:1–8
  3. Ciardella AP, Donsoff IM, Huang SJ, et al. Polypoidal choroidal vasculopathy. Surv Ophthalmol. 2004;49:25–37
  4. Costa RA, Navajas EV, Farah ME, et al. Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm. Prog Retin Eye Res. 2005;24:560–586
  5. Sho K, Takahashi K, Yamada H, et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol. 2003;121:1392–1396
  6. Uyama M, Wada M, Nagai Y, et al. Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol. 2002;133:639–648
  7. Uyama M, Matsubara T, Fukushima I, et al. Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol. 1999;117:1035–1042
  8. Ahuja RM, Stanga PE, Vingerling JR, et al. Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments. Br J Ophthalmol. 2000;84:479–484
  9. Spaide RF, Yannuzzi LA, Slakter JS, et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina. 1995;15:100–110
  10. Yannuzzi LA, Wong DW, Sforzolini BS, et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol. 1999;117:1503–1510
  11. Quaranta M, Mauget-Faysse M, Coscas G. Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Am J Ophthalmol. 2002;134:277–280
  12. Chan WM, Lam DS, Lai TY, et al. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Ophthalmology. 2004;111:1576–1584
  13. Lee SC, Seong YS, Kim SS, et al. Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula. Ophthalmologica. 2004;218:193–201
  14. Hussain N, Hussain A, Natarajan S. Role of photodynamic therapy in polypoidal choroidal vasculopathy. Indian J Ophthalmol. 2005;53:101–104
  15. Spaide RF, Donsoff I, Lam DL, et al. Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. Retina. 2002;22:529–535
  16. Springer C, Bultmann S, Volcker HE, Rohrschneider K. Fundus perimetry with the Micro Perimeter 1 in normal individuals: comparison with conventional threshold perimetry. Ophthalmology. 2005;112:848–854
  17. Rohrschneider K, Springer C, Bultmann S, Volcker HE. Microperimetry—comparison between the Micro Perimeter 1 and scanning laser ophthalmoscope—fundus perimetry. Am J Ophthalmol. 2005;139:125–134
  18. Schmidt-Erfurth UM, Elsner H, Terai N, et al. Effects of verteporfin therapy on central visual field function. Ophthalmology. 2004;111:931–939
  19. Varano M, Parisi V, Tedeschi M, et al. Macular function after PDT in myopic maculopathy: psychophysical and electrophysiological evaluation. Invest Ophthalmol Vis Sci. 2005;46:1453–1462
  20. Imai H, Honda S, Nakanishi Y, et al. Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy. Br J Ophthalmol. 2006;90:1524–1530
  21. Ojima Y, Tsujikawa A, Otani A, et al. Recurrent bleeding after photodynamic therapy in polypoidal choroidal vasculopathy. Am J Ophthalmol. 2006;141:958–960
  22. Hirami Y, Tsujikawa A, Otani A, et al. Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy. Retina. Forthcoming.
  23. Silva RM, Figueira J, Cachulo ML, et al. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol. 2005;243:973–979
  24. Ozdemir H, Karacorlu SA, Karacorlu M. Early optical coherence tomography changes after photodynamic therapy in patients with age-related macular degeneration. Am J Ophthalmol. 2006;141:574–576
  25. Costa RA, Farah ME, Cardillo JA, et al. Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization. Retina. 2003;23:159–165
  26. Montero JA, Ruiz-Moreno JM, Tavolato M. Follow-up of age-related macular degeneration patients treated by photodynamic therapy with optical coherence tomography 3. Graefes Arch Clin Exp Ophthalmol. 2003;241:797–802
  27. Tezel TH, Del Priore LV, Flowers BE, et al. Correlation between scanning laser ophthalmoscope microperimetry and anatomic abnormalities in patients with subfoveal neovascularization. Ophthalmology. 1996;103:1829–1836
  28. Ergun E, Maar N, Radner W, et al. Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2003;110:65–69
  29. Nilsson UL, Frennesson C, Nilsson SE. Patients with AMD and a large absolute central scotoma can be trained successfully to use eccentric viewing, as demonstrated in a scanning laser ophthalmoscope. Vision Res. 2003;43:1777–1787
  30. Takamine Y, Shiraki K, Moriwaki M, et al. Retinal sensitivity measurement over drusen using scanning laser ophthalmoscope microperimetry. Graefes Arch Clin Exp Ophthalmol. 1998;236:285–290
  31. Midena E, Radin PP, Pilotto E, et al. Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration; a Microperimetry Study. Semin Ophthalmol. 2004;19:55–61
  32. Jarc-Vidmar M, Popovic P, Hawlina M. Mapping of central visual function by microperimetry and autofluorescence in patients with Best’s vitelliform dystrophy. Eye. 2006;20:688–696
  33. Okada K, Yamamoto S, Mizunoya S, et al. Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema. Eye. 2006;20:805–809
  34. Sawa M, Gomi F, Toyoda A, et al. A microperimeter that provides fixation pattern and retinal sensitivity measurement. Jpn J Ophthalmol. 2006;50:111–115

PII: S0002-9394(07)00066-9

doi: 10.1016/j.ajo.2007.01.026

American Journal of Ophthalmology
Volume 143, Issue 6 , Pages 984-994.e1 , June 2007

Article Tools

* Image Usage & Resolution